895233

AstraZeneca Pharmaceuticals, LP — FEI 2517100

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 27, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Newark, DE (United States)

Citations

IDCFRDescription
430321 CFR 211.67(b)Written procedures fail to include